Ask what causes cervical cancer and, these days, almost everyone gives the same one-word answer: HPV — the human papillomavirus, the sexually transmitted infection a vaccine now guards against. That answer is correct as far as it goes. Persistent infection with a high-risk strain of HPV is present in nearly every cervical cancer, and the arrival of the HPV vaccine and Pap-and-HPV screening are among the great public-health achievements of the last half-century. But the one-word answer leaves something out, something the United States government put in writing more than twenty years ago: cigarette smoking is also a cause of cervical cancer. In its 2004 report, the Surgeon General concluded that smoking causes the disease, and the International Agency for Research on Cancer reached the same conclusion that year. Most women were never told. The warning label never mentioned the cervix, and the advertising certainly never did.
This piece continues the firm's series on the smoking-caused cancers the public rarely hears about — alongside our guides to liver cancer, kidney cancer, pancreatic cancer, stomach cancer, and colorectal cancer. Cervical cancer belongs on that list too. Below: what cervical cancer is, why it sits on the Surgeon General's smoking list, the biology that explains how a cigarette reaches the cervix, how large the risk really is, a distinctive fact these cases turn on — the way the smoking link attaches to one cell type and not the other — the “it was just the HPV” defense the tobacco companies raise, and how a smoking-related cervical cancer claim fits the same liability framework the firm uses in its lung cancer, COPD, and other smoking-disease matters.
What Cervical Cancer Is
Cervical cancer begins in the cervix, the lower, narrow end of the uterus that opens into the vagina. Like several other cancers in this series, it is really more than one disease. The two main types are named for the cells they arise from. Squamous cell carcinoma starts in the thin, flat squamous cells that line the outer surface of the cervix; it is the more common form, historically accounting for the large majority of cases. Adenocarcinoma starts in the gland cells of the cervical canal. That distinction is not academic here — as explained below, smoking is tied to one of these types and not the other, which is exactly the kind of detail that decides how a case is built.
Cervical cancer is unusual among the cancers in this series in that it is largely preventable and, when caught early, highly treatable. It typically develops slowly, over years, through pre-cancerous changes — cervical intraepithelial neoplasia, or CIN — that a Pap smear or HPV test can catch before they ever become cancer. Early cervical cancer often causes no symptoms at all. When symptoms do appear — abnormal bleeding between periods or after intercourse, unusual discharge, pelvic pain — the disease may already be more advanced. That is why screening matters so much, and why a cancer that slips through, in a woman with a long smoking history, deserves a careful look at every factor that contributed to it.
Why Cervical Cancer Is on the Surgeon General's Smoking List
The link between smoking and cervical cancer is not a plaintiff's theory. It is the conclusion of the United States government's highest scientific authority on tobacco and of the world's leading cancer-research body. The 2004 Surgeon General's report, The Health Consequences of Smoking, formally concluded that the evidence is sufficient to infer a causal relationship between cigarette smoking and cervical cancer — part of the same landmark report that expanded the official list to include cervical, stomach, kidney, and pancreatic cancers and acute myeloid leukemia. That same year, the International Agency for Research on Cancer (IARC) classified the evidence linking tobacco smoking to cervical cancer as sufficient. The National Cancer Institute and the American Cancer Society both identify smoking as a risk factor for cervical cancer, noting that women who smoke are about twice as likely to develop it as women who do not.
The biology explains how an organ that never touches smoke is harmed by it, and it also explains why smoking and HPV are so tightly bound together in this cancer. Cigarette smoke carries dozens of established carcinogens — including benzo[a]pyrene, a polycyclic aromatic hydrocarbon, and tobacco-specific nitrosamines. These and their breakdown products are absorbed into the bloodstream through the lungs and carried throughout the body; researchers have measured tobacco carcinogens and their metabolites, including cotinine and benzo[a]pyrene, in the cervical mucus of women who smoke, at times in concentrations higher than in their blood. There, they can bind to and damage the DNA of cervical cells. Smoking also appears to suppress the local immune defenses of the cervix — reducing the Langerhans cells that help the body recognize and clear an HPV infection — so that a virus a nonsmoker's immune system might have cleared instead persists, and persistence is what drives the progression from infection to cancer. An organ does not have to inhale smoke to be poisoned by it.
How Big Is the Smoking Risk?
Elevated, and specific in a telling way. The most comprehensive measurement is a collaborative reanalysis of individual data on 13,541 women with cervical carcinoma and 23,017 women without it, drawn from 23 epidemiological studies and published in the International Journal of Cancer in 2006 by the International Collaboration of Epidemiological Studies of Cervical Cancer. Its findings, comparing current smokers with women who never smoked:
- Current smokers had about 1.60 times the risk of squamous cell carcinoma of the cervix (95% confidence interval 1.48–1.73) — roughly a 60 percent increase.
- Among women who tested positive for cervical HPV, the risk in current smokers rose to about 1.95 times (95% confidence interval 1.43–2.65) — a nearly two-fold increase in exactly the group in which cervical cancer actually develops.
- There was a clear dose-response: the risk of squamous cell carcinoma climbed with the number of cigarettes smoked per day and with a younger age at starting to smoke — the gradient epidemiologists rely on to separate genuine causation from coincidence.
- The increased risk was confined to squamous cell carcinoma. For adenocarcinoma, even among HPV-positive women, current smokers showed no increased risk (relative risk 1.06).
A roughly 60 percent increase — nearly doubling among the HPV-positive women in whom the disease arises — is not a minor effect. And because cervical cancer so often grows out of pre-cancerous changes that smoking helps push forward, the harm is not only in the tumors that form but in the infections that, but for the cigarettes, might have quietly cleared.
A Distinctive Fact: The Link Is to Squamous Cell Carcinoma, Not Adenocarcinoma
Cervical cancer cases carry a feature that sets them apart from many other smoking-disease cases, and it comes straight from the science. The smoking association is not spread evenly across the disease. It attaches to squamous cell carcinoma — the type that arises on the outer surface of the cervix, the surface most exposed to carcinogens carried in cervical mucus — and not to adenocarcinoma of the gland cells deeper in the canal. When a woman's tumor is a squamous cell carcinoma, its very cell type is consistent with the route cigarette carcinogens travel, a detail that a general reading of “cervical cancer” would flatten but that matters in building the causal story. This mirrors the split the firm describes in its esophageal cancer guide, where the smoking link likewise tracks the squamous cell type.
This is the kind of record where the firm's Medical-Legal Expert earns his place. Herb Borroto, M.D., J.D., who holds both a medical degree and a law degree, reads the pathology and histology reports, the cell type and staging, the HPV testing and any record of prior abnormal Pap results or CIN, and the smoking history together — recognizing when the cell type and course of a cervical cancer support the causal story, in a way a purely legal review has no reason to look for and a purely clinical review has no reason to connect to liability.
The “It Was Just the HPV” Defense
Cervical cancer has a well-known necessary cause — persistent high-risk HPV infection — and tobacco defendants know it. Expect the familiar move: point to something other than the cigarettes. She had HPV. Nearly every cervical cancer does. The virus caused it, not our product. The argument trades on a real fact: HPV is found in almost all cervical cancers, and without it the disease would be vanishingly rare. It does not end the case.
The reason is that HPV infection, by itself, usually does not lead to cancer. Most women who acquire HPV clear the virus within a couple of years and never develop disease. What separates a cleared infection from a persistent one that progresses to cancer is a set of cofactors — and the Surgeon General and IARC weighed the whole body of evidence before concluding that smoking is one of them, and an independent cause of the disease. Smoking and HPV act together: the carcinogens damage the DNA of cells the virus has already made vulnerable, and the immune suppression helps the virus persist in the first place. A cause does not have to be the only cause. In product-liability law, a manufacturer whose product was a substantial contributing factor to an injury does not escape responsibility merely by naming another factor that also played a part. And here the plaintiff often has something concrete to answer the deflection with: a substantial smoking history, the dose-response by cigarettes per day, and — where the pathology shows it — a squamous cell carcinoma, the type the science ties to cigarettes. The presence of HPV becomes part of the full picture the jury weighs, not an automatic answer to it.
The Legal Framework
Smoking-related cervical cancer cases proceed on the same liability theories as other smoking-disease cases against the tobacco industry:
- Negligent design, manufacture, and marketing of cigarettes.
- Strict product liability for an unreasonably dangerous product.
- Failure to warn about the full range of cancers smoking causes — including cancers, like cervical cancer, of organs far from the lungs.
- Fraud and misrepresentation about the safety and addictiveness of the products.
- Civil conspiracy among manufacturers to suppress and distort health research.
The internal industry records unearthed in prior tobacco litigation — the documents showing what the companies knew about the harms of their product and when — remain central evidence. Our companion piece on how tobacco companies hid the truth walks through that record. Alex Alvarez, the firm's Managing Partner and a Board Certified Civil Trial Lawyer, brings that documentary history together with each client's own smoking and medical records to build the causation case a cervical cancer claim requires — including the answer to the “it was just the HPV” defense described above. The carcinogen science here overlaps closely with the firm's lung cancer cases and its other smoking-caused cancer matters.
What a Cervical Cancer Case Needs
- Documentation of the diagnosis — the biopsy or surgical pathology confirming cervical cancer, the cell type (squamous cell versus adenocarcinoma), and the staging.
- The HPV testing and any history of abnormal Pap results, CIN, or prior treatment, so those findings can be placed in context rather than left for the defense to spring.
- A substantial smoking history, measured in pack-years, spanning the years the science associates with the disease.
- Brand identification — which cigarettes were smoked, and for how long.
- The medical history that bears on the other recognized cofactors, so the smoking contribution can be shown alongside them rather than against them.
- Causation testimony from an appropriate expert familiar with the smoking–cervical cancer literature.
- Documentation of the disease's impact — the surgery, chemotherapy or radiation, any recurrence, the decline, and, in cases brought after a death, the cause-of-death records.
The unglamorous paperwork behind these elements is what carries a case. Our guide to smoking history documentation covers the records that build or break a tobacco claim, and our wrongful death family guide walks through what a family should know when cervical cancer has taken a loved one.
The Jurisdictions We Serve
The Alvarez Law Firm represents smokers and families in Hawaii, Illinois, Nevada, Oregon, Pennsylvania, and the U.S. Virgin Islands. Each of those jurisdictions has its own filing deadlines, its own substantive law on tobacco product liability, and its own version of the discovery rule — how long after a diagnosis, or a death, a claim must be filed. Because those deadlines are unforgiving and easy to overlook while a family is absorbed in treatment, talk to counsel licensed in the relevant state about how they apply to your situation. Waiting can foreclose options that were available earlier.
Frequently Asked Questions
Does smoking cause cervical cancer?
Yes. The 2004 Surgeon General's report, The Health Consequences of Smoking, concluded that the evidence is sufficient to infer a causal relationship between cigarette smoking and cervical cancer, and the International Agency for Research on Cancer classified the evidence as sufficient the same year. Nearly all cervical cancer also requires a persistent human papillomavirus (HPV) infection, and smoking works together with HPV rather than in place of it: tobacco carcinogens have been measured in the cervical mucus of smokers, and smoking weakens the local immune response that would otherwise help clear the virus.
How much does smoking raise the risk of cervical cancer?
A collaborative reanalysis of individual data on more than 13,000 women with cervical carcinoma from 23 epidemiological studies, published in the International Journal of Cancer in 2006, found that current smokers had about 1.60 times the risk of squamous cell carcinoma of the cervix compared with never-smokers. Among women who tested positive for cervical HPV, the risk in current smokers rose to about 1.95 times. The risk climbed with more cigarettes per day and with a younger age at starting to smoke, and the association was specific to squamous cell carcinoma rather than adenocarcinoma.
Can you file a cervical cancer lawsuit if HPV was involved?
Potentially. Human papillomavirus is present in nearly all cervical cancers, and tobacco defendants routinely point to it. But most women who acquire HPV clear it, and smoking is a recognized cofactor that helps the virus persist and progress to cancer. The two act together, not one in place of the other. Product-liability law does not excuse a manufacturer whose product was a substantial contributing factor merely because another factor also played a part. A longtime smoker diagnosed with cervical cancer, or a family that lost someone to it, should speak with counsel licensed in the relevant state, because every jurisdiction has its own filing deadline.
If You or a Family Member Has Been Diagnosed
If you have a substantial smoking history and have been diagnosed with cervical cancer — or your family lost a loved one to it — a free, confidential case review is the right next step. The same conversation that produces a viable lung cancer case can produce a viable cervical cancer case.
- Read about the firm's other smoking-caused cancer cases: Esophageal Cancer, Stomach Cancer, Liver Cancer, and Colorectal Cancer.
- Read the wrongful death family guide: Smokers Wrongful Death Family Guide.
- Learn how the industry concealed the harms: How Tobacco Companies Hid the Truth.
Free case review. No fees unless we recover compensation for you.
Sources
- U.S. Surgeon General — "The Health Consequences of Smoking" (2004), which concluded the evidence is sufficient to infer a causal relationship between smoking and cervical cancer, and "The Health Consequences of Smoking—50 Years of Progress" (2014). cdc.gov/tobacco/sgr
- International Collaboration of Epidemiological Studies of Cervical Cancer — "Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies." International Journal of Cancer, 2006;118(6):1481–1495 — current smokers relative risk 1.60 for squamous cell carcinoma, 1.95 among HPV-positive women, no increased risk for adenocarcinoma, with a dose-response by cigarettes per day. pubmed.ncbi.nlm.nih.gov
- International Agency for Research on Cancer (IARC) — Monograph on tobacco smoke (2004), classifying the evidence for smoking and cervical cancer as sufficient. publications.iarc.fr
- National Cancer Institute — "Cervical Cancer Prevention (PDQ)," identifying cigarette smoking as a risk factor associated with squamous cell cervical cancer. cancer.gov
- American Cancer Society — "Cervical Cancer Risk Factors," noting that women who smoke are about twice as likely as nonsmokers to develop cervical cancer and that tobacco by-products have been found in the cervical mucus of smokers. cancer.org